These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10971664)

  • 1. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
    Caruso JM; Brown WD; Exil G; Gascon GG
    Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
    Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
    Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
    Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group.
    Silberstein SD; Collins SD
    Headache; 1999 Oct; 39(9):633-43. PubMed ID: 11284461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
    Kaniecki RG
    Arch Neurol; 1997 Sep; 54(9):1141-5. PubMed ID: 9311358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
    Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex in the long-term treatment of chronic daily headache.
    Freitag FG; Diamond S; Diamond ML; Urban GJ
    Headache; 2001 Mar; 41(3):271-8. PubMed ID: 11264687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric migraine prophylaxis with divalproex.
    Pakalnis A; Greenberg G; Drake ME; Paolichi J
    J Child Neurol; 2001 Oct; 16(10):731-4. PubMed ID: 11669346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic daily posttraumatic headache with divalproex sodium.
    Packard RC
    Headache; 2000 Oct; 40(9):736-9. PubMed ID: 11091292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.
    Green MW; Giordano S; Jiang P; Jafari M; Smith TB
    Headache; 2005 Sep; 45(8):1031-7. PubMed ID: 16109117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine prophylaxis with divalproex.
    Mathew NT; Saper JR; Silberstein SD; Rankin L; Markley HG; Solomon S; Rapoport AM; Silber CJ; Deaton RL
    Arch Neurol; 1995 Mar; 52(3):281-6. PubMed ID: 7872882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM; Schim JD; Chippendale TJ
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalproex sodium extended-release for the prophylaxis of migraine headache.
    Freitag FG
    Expert Opin Pharmacother; 2003 Sep; 4(9):1573-8. PubMed ID: 12943487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
    Bidabadi E; Mashouf M
    Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the "carry-over effect" following successful short-term treatment of transformed migraine with divalproex sodium.
    Rothrock JF; Mendizabal JE
    Headache; 2000 Jan; 40(1):17-9. PubMed ID: 10759897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
    Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
    Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.